21:38 , Jan 5, 2018 |  BC Week In Review  |  Financial News

Oculis raises CHF20M series B

Oculis S.A. (Lausanne, Switzerland) raised CHF20 million ($20.3 million) on Jan. 4 in a tranched series B round led by Bay City Capital, Novartis Venture Fund and Pivotal bioVenture Partners with participation by existing investors...
08:02 , Jan 4, 2018 |  BC Extra  |  Financial News

Oculis raises CHF20M series B

Oculis ehf (Lausanne, Switzerland) raised CHF20 million ($20.3 million) in a series B round led by Bay City Capital, Novartis Venture Fund and Pivotal bioVenture Partners. Existing investors Brunnur Ventures and Silfurberg also participated. The...
07:00 , Aug 22, 2016 |  BC Week In Review  |  Financial News

Oculis completes venture financing

Oculis ehf , Reykjavik, Iceland   Business: Drug delivery, Ophthalmic   Date completed: 2016-08-16   Type: Venture financing   Raised: Not disclosed   Investors: Brunnur Ventures; Silfurberg   Note: The amount raised is not disclosed....